Skip to main content
. 2018 Dec 4;9(95):36736–36749. doi: 10.18632/oncotarget.26314

Figure 3. Evaluation of CRBPI, CRABPII and RXRα expression in imiquimod-induced psoriatic skin of CRBPI-knockout and wild-type mice.

Figure 3

(A) Representative CRBPI, CRABP-II and RXRα immunostainings of wild-type (WT) and CRBPI-knockout (KO) mice skin after 6 days of treatment with control cream (vehicle) or imiquimod (IMQ). Original magnification 200X; (B) Bar graphs show the semiquantitative evaluation of CRBPI, CRABPII and RXRα immunostainings. Results are expressed as mean values±SEM (n=8 mice per group); ANOVA #p < 0.005, ##p < 0.0005, ###p < 0.000005. *p < 0.05; **p < 0.01;***p< 0.001 at Student’s t-test.